Physician profile
Austin Davidson
NPI 1598185092
$56,350.85
in general payments reported to CMS, 2019-2025
19 companies · $43K in 2025
The $43K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $228 · 2021: $4,674 · 2022: $4,138 · 2023: $2,493 · 2024: $1,897 · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $42K · Travel and Lodging: $3,133 · Food and Beverage: $1,822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $41,947.06 |
| Travel and Lodging | $3,132.51 |
| Food and Beverage | $1,822.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forma Medical | $36,247.06 | 2024-2025 | Optimalmtp |
| Kuros Biosciences USA, INC | $6,961.23 | 2025 | Magnetos |
| Alpha Orthopedic Systems | $5,203.20 | 2020-2023 | |
| Vilex LLC | $2,584.26 | 2023-2024 | |
| Arthrex, INC. | $2,280.00 | 2021 | |
| Treace Medical Concepts, INC. | $854.41 | 2021 | |
| Stryker Corporation | $791.54 | 2021-2025 | Inbone, Ortholoc 3di, Ortholoc 2 Lapifuse |
| Medical Device Business Services, INC. | $329.99 | 2019 | |
| Smoky Mountain Surgical LLC | $248.24 | 2024-2025 | |
| Smith+Nephew, INC. | $223.22 | 2022-2024 | Stravix Pl, Stravix, Grafix Pl |
| Paragon 28, INC. | $216.94 | 2020-2023 | Additive Orthopedics |
| Biotissue Holdings INC. | $148.48 | 2020 | |
| Linvatec Corporation | $117.63 | 2024 | Biobrace 23mm, Hall Power |
| Integra Lifesciences Corporation | $55.37 | 2019 | |
| Orthofix Medical, INC. | $23.24 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $19.67 | 2024 | Austedo Xr |
| Exactech, INC. | $17.45 | 2022 | |
| In2bones USA, LLC | $15.81 | 2021 | |
| Horizon Therapeutics Plc | $13.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Davidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.